UnitedHealth Group Incorporated (UNH) Stake Decreased by American National Bank
American National Bank reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,728 shares of the healthcare conglomerate’s stock after selling 449 shares during the period. UnitedHealth Group accounts for about 1.9% of American National Bank’s investment portfolio, making the stock its 13th largest position. American National Bank’s holdings in UnitedHealth Group were worth $5,883,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently made changes to their positions in UNH. Naples Global Advisors LLC raised its holdings in UnitedHealth Group by 329.3% in the first quarter. Naples Global Advisors LLC now owns 8,122 shares of the healthcare conglomerate’s stock valued at $1,332,000 after buying an additional 6,230 shares during the period. V Wealth Management LLC purchased a new position in UnitedHealth Group in the first quarter valued at approximately $355,000. Factory Mutual Insurance Co. raised its holdings in UnitedHealth Group by 4.6% in the first quarter. Factory Mutual Insurance Co. now owns 344,600 shares of the healthcare conglomerate’s stock valued at $56,518,000 after buying an additional 15,000 shares during the period. Candriam Luxembourg S.C.A. raised its holdings in UnitedHealth Group by 15.0% in the first quarter. Candriam Luxembourg S.C.A. now owns 168,372 shares of the healthcare conglomerate’s stock valued at $27,616,000 after buying an additional 21,943 shares during the period. Finally, CAPROCK Group Inc. raised its holdings in UnitedHealth Group by 13.1% in the first quarter. CAPROCK Group Inc. now owns 6,243 shares of the healthcare conglomerate’s stock valued at $1,024,000 after buying an additional 724 shares during the period. Institutional investors and hedge funds own 86.21% of the company’s stock.
Several research firms recently commented on UNH. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Cantor Fitzgerald restated a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 29th. UBS AG restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Jefferies Group LLC restated a “buy” rating and issued a $215.00 price target on shares of UnitedHealth Group in a report on Friday, August 18th. Finally, Morgan Stanley raised their price target on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. One analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $203.41.
ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Incorporated (UNH) Stake Decreased by American National Bank” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/09/15/unitedhealth-group-incorporated-unh-stake-decreased-by-american-national-bank.html.
UnitedHealth Group Incorporated (NYSE UNH) traded up 0.32% during mid-day trading on Friday, hitting $198.37. 2,436,640 shares of the stock were exchanged. UnitedHealth Group Incorporated has a one year low of $133.03 and a one year high of $200.76. The company has a 50-day moving average price of $195.02 and a 200-day moving average price of $180.41. The company has a market cap of $191.80 billion, a P/E ratio of 23.83 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same period in the previous year, the company earned $1.96 earnings per share. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the transaction, the director now directly owns 76,058 shares in the company, valued at $14,753,730.84. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the transaction, the director now owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 25,600 shares of company stock valued at $4,962,694. Corporate insiders own 0.89% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.